Review




Structured Review

Jackson Laboratory the jackson clinical knowledgebase
The Jackson Clinical Knowledgebase, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/clinical+knowledgebase/jackson+clinical+knowledgebase/pm40154350-4-8-12
Average 90 stars, based on 1 article reviews
the jackson clinical knowledgebase - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Variant Assay:

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: , The Jackson Laboratory Clinical Knowledgebase (JAX) , https://ckb.jax.org.

Article Title: Basket Trials: Past, Present, and Future
Article Snippet: Online databases have been developed to determine the predictive role of molecular alterations; these include OncoKB, OncoVAR, Jackson Laboratory Clinical Knowledgebase, CIViC, Precision Medicine Knowledgebase, MyCancerGenome, Cancer Genome Interpreter, CancerVar, MetaKB, and ClinVar.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: TP53 mutational information is from the supplementary data of Yang et al.; TP53 status of each model was classified as non-pathogenic, pathogenic, or having conflicting evidence based on annotations from OncoKB, ClinVar, CIViC, and/or the Jackson Laboratory Clinical KnowledgeBase (JAX CKB). (b) Yang dataset (graphical view of TP53 mutation data is shown in Fig. a); 13 models were resistant to gemcitabine and 15 models were sensitive as determined by the evaluation of percentage tumor growth inhibition (TGI%).

Article Title: A clinical solution for tracking clonal evolution of acute myeloid leukemia after allogeneic transplantation using bulk next generation sequencing.
Article Snippet: Clinical next generation sequencing (NGS) typically relies on limited gene panels run on bulk marrow or blood.. Current computational tools for inferring clonal relationships is generally limited by the use of a small panel of pathogenic mutations to define clones.. We developed an online software (CloneTracker) that uses ‘incidentally-sequenced’ single nucleotide polymorphisms (SNPs) in the regions of recurrent somatic mutations in addition to conventional mutation data from bulk NGS gene panels to provide detailed visualizations of clonal evolution during cancer treatment, alongside clinical data.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: Briefly, information about functional effects of TP53 mutation variants was obtained from the OncoKB and compared to the information from ClinVar, CiViC, and the Jackson Laboratory Clinical KnowledgeBase (JAX CKB) databases, and from biomedical publications.

Article Title: CGE25-107: Capture Efficacy of Genomic Panels for NCCN-Recommended and Clinical Trial Associated Biomarkers.
Article Snippet: CGE25-107: Capture Efficacy of Genomic Panels for NCCNRecommended and Clinical Trial Associated Biomarkers Authors: J... VIEW MORE Volume/Issue: Volume 23: Issue 3.5 Online Publication Date: 28 Mar 2025 DOI: https://doi.org/10.6004/jnccn.2025.70 05 GET PERMISSIONS Introduction: Knowledge of treatment options, including FDA-approved targeted therapies and potential clinical trial eligibility, enables oncologists to develop optimal treatment plans for patients with advanced or metastatic cancer.. National guidelines strongly endorse testing for targeted therapies and patient participation in clinical trials.. This study analyzed commercially available NGS panels of varying sizes to assess their ability to capture genomic variants linked to NCCN-recommended and clinical trialassociated targeted treatments for high incidence cancers.

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: They host the Jackson Laboratory Clinical Knowledgebase (JAX-CKB) ( https://ckb.jax.org ), which is an interactive digital resource for interpreting complex cancer genomic profiles, providing clinical context to genomic and protein data [ , ].

Clinical Proteomics:

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: , The Jackson Laboratory Clinical Knowledgebase (JAX) , https://ckb.jax.org.

Article Title: Basket Trials: Past, Present, and Future
Article Snippet: Online databases have been developed to determine the predictive role of molecular alterations; these include OncoKB, OncoVAR, Jackson Laboratory Clinical Knowledgebase, CIViC, Precision Medicine Knowledgebase, MyCancerGenome, Cancer Genome Interpreter, CancerVar, MetaKB, and ClinVar.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: TP53 mutational information is from the supplementary data of Yang et al.; TP53 status of each model was classified as non-pathogenic, pathogenic, or having conflicting evidence based on annotations from OncoKB, ClinVar, CIViC, and/or the Jackson Laboratory Clinical KnowledgeBase (JAX CKB). (b) Yang dataset (graphical view of TP53 mutation data is shown in Fig. a); 13 models were resistant to gemcitabine and 15 models were sensitive as determined by the evaluation of percentage tumor growth inhibition (TGI%).

Article Title: A clinical solution for tracking clonal evolution of acute myeloid leukemia after allogeneic transplantation using bulk next generation sequencing.
Article Snippet: Clinical next generation sequencing (NGS) typically relies on limited gene panels run on bulk marrow or blood.. Current computational tools for inferring clonal relationships is generally limited by the use of a small panel of pathogenic mutations to define clones.. We developed an online software (CloneTracker) that uses ‘incidentally-sequenced’ single nucleotide polymorphisms (SNPs) in the regions of recurrent somatic mutations in addition to conventional mutation data from bulk NGS gene panels to provide detailed visualizations of clonal evolution during cancer treatment, alongside clinical data.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: Briefly, information about functional effects of TP53 mutation variants was obtained from the OncoKB and compared to the information from ClinVar, CiViC, and the Jackson Laboratory Clinical KnowledgeBase (JAX CKB) databases, and from biomedical publications.

Article Title: CGE25-107: Capture Efficacy of Genomic Panels for NCCN-Recommended and Clinical Trial Associated Biomarkers.
Article Snippet: CGE25-107: Capture Efficacy of Genomic Panels for NCCNRecommended and Clinical Trial Associated Biomarkers Authors: J... VIEW MORE Volume/Issue: Volume 23: Issue 3.5 Online Publication Date: 28 Mar 2025 DOI: https://doi.org/10.6004/jnccn.2025.70 05 GET PERMISSIONS Introduction: Knowledge of treatment options, including FDA-approved targeted therapies and potential clinical trial eligibility, enables oncologists to develop optimal treatment plans for patients with advanced or metastatic cancer.. National guidelines strongly endorse testing for targeted therapies and patient participation in clinical trials.. This study analyzed commercially available NGS panels of varying sizes to assess their ability to capture genomic variants linked to NCCN-recommended and clinical trialassociated targeted treatments for high incidence cancers.

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: They host the Jackson Laboratory Clinical Knowledgebase (JAX-CKB) ( https://ckb.jax.org ), which is an interactive digital resource for interpreting complex cancer genomic profiles, providing clinical context to genomic and protein data [ , ].

Biomarker Assay:

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: , The Jackson Laboratory Clinical Knowledgebase (JAX) , https://ckb.jax.org.

Article Title: Basket Trials: Past, Present, and Future
Article Snippet: Online databases have been developed to determine the predictive role of molecular alterations; these include OncoKB, OncoVAR, Jackson Laboratory Clinical Knowledgebase, CIViC, Precision Medicine Knowledgebase, MyCancerGenome, Cancer Genome Interpreter, CancerVar, MetaKB, and ClinVar.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: TP53 mutational information is from the supplementary data of Yang et al.; TP53 status of each model was classified as non-pathogenic, pathogenic, or having conflicting evidence based on annotations from OncoKB, ClinVar, CIViC, and/or the Jackson Laboratory Clinical KnowledgeBase (JAX CKB). (b) Yang dataset (graphical view of TP53 mutation data is shown in Fig. a); 13 models were resistant to gemcitabine and 15 models were sensitive as determined by the evaluation of percentage tumor growth inhibition (TGI%).

Article Title: A clinical solution for tracking clonal evolution of acute myeloid leukemia after allogeneic transplantation using bulk next generation sequencing.
Article Snippet: Clinical next generation sequencing (NGS) typically relies on limited gene panels run on bulk marrow or blood.. Current computational tools for inferring clonal relationships is generally limited by the use of a small panel of pathogenic mutations to define clones.. We developed an online software (CloneTracker) that uses ‘incidentally-sequenced’ single nucleotide polymorphisms (SNPs) in the regions of recurrent somatic mutations in addition to conventional mutation data from bulk NGS gene panels to provide detailed visualizations of clonal evolution during cancer treatment, alongside clinical data.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: Briefly, information about functional effects of TP53 mutation variants was obtained from the OncoKB and compared to the information from ClinVar, CiViC, and the Jackson Laboratory Clinical KnowledgeBase (JAX CKB) databases, and from biomedical publications.

Article Title: CGE25-107: Capture Efficacy of Genomic Panels for NCCN-Recommended and Clinical Trial Associated Biomarkers.
Article Snippet: CGE25-107: Capture Efficacy of Genomic Panels for NCCNRecommended and Clinical Trial Associated Biomarkers Authors: J... VIEW MORE Volume/Issue: Volume 23: Issue 3.5 Online Publication Date: 28 Mar 2025 DOI: https://doi.org/10.6004/jnccn.2025.70 05 GET PERMISSIONS Introduction: Knowledge of treatment options, including FDA-approved targeted therapies and potential clinical trial eligibility, enables oncologists to develop optimal treatment plans for patients with advanced or metastatic cancer.. National guidelines strongly endorse testing for targeted therapies and patient participation in clinical trials.. This study analyzed commercially available NGS panels of varying sizes to assess their ability to capture genomic variants linked to NCCN-recommended and clinical trialassociated targeted treatments for high incidence cancers.

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: They host the Jackson Laboratory Clinical Knowledgebase (JAX-CKB) ( https://ckb.jax.org ), which is an interactive digital resource for interpreting complex cancer genomic profiles, providing clinical context to genomic and protein data [ , ].

Biomarker Discovery:

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: , The Jackson Laboratory Clinical Knowledgebase (JAX) , https://ckb.jax.org.

Article Title: Basket Trials: Past, Present, and Future
Article Snippet: Online databases have been developed to determine the predictive role of molecular alterations; these include OncoKB, OncoVAR, Jackson Laboratory Clinical Knowledgebase, CIViC, Precision Medicine Knowledgebase, MyCancerGenome, Cancer Genome Interpreter, CancerVar, MetaKB, and ClinVar.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: TP53 mutational information is from the supplementary data of Yang et al.; TP53 status of each model was classified as non-pathogenic, pathogenic, or having conflicting evidence based on annotations from OncoKB, ClinVar, CIViC, and/or the Jackson Laboratory Clinical KnowledgeBase (JAX CKB). (b) Yang dataset (graphical view of TP53 mutation data is shown in Fig. a); 13 models were resistant to gemcitabine and 15 models were sensitive as determined by the evaluation of percentage tumor growth inhibition (TGI%).

Article Title: A clinical solution for tracking clonal evolution of acute myeloid leukemia after allogeneic transplantation using bulk next generation sequencing.
Article Snippet: Clinical next generation sequencing (NGS) typically relies on limited gene panels run on bulk marrow or blood.. Current computational tools for inferring clonal relationships is generally limited by the use of a small panel of pathogenic mutations to define clones.. We developed an online software (CloneTracker) that uses ‘incidentally-sequenced’ single nucleotide polymorphisms (SNPs) in the regions of recurrent somatic mutations in addition to conventional mutation data from bulk NGS gene panels to provide detailed visualizations of clonal evolution during cancer treatment, alongside clinical data.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: Briefly, information about functional effects of TP53 mutation variants was obtained from the OncoKB and compared to the information from ClinVar, CiViC, and the Jackson Laboratory Clinical KnowledgeBase (JAX CKB) databases, and from biomedical publications.

Article Title: CGE25-107: Capture Efficacy of Genomic Panels for NCCN-Recommended and Clinical Trial Associated Biomarkers.
Article Snippet: CGE25-107: Capture Efficacy of Genomic Panels for NCCNRecommended and Clinical Trial Associated Biomarkers Authors: J... VIEW MORE Volume/Issue: Volume 23: Issue 3.5 Online Publication Date: 28 Mar 2025 DOI: https://doi.org/10.6004/jnccn.2025.70 05 GET PERMISSIONS Introduction: Knowledge of treatment options, including FDA-approved targeted therapies and potential clinical trial eligibility, enables oncologists to develop optimal treatment plans for patients with advanced or metastatic cancer.. National guidelines strongly endorse testing for targeted therapies and patient participation in clinical trials.. This study analyzed commercially available NGS panels of varying sizes to assess their ability to capture genomic variants linked to NCCN-recommended and clinical trialassociated targeted treatments for high incidence cancers.

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: They host the Jackson Laboratory Clinical Knowledgebase (JAX-CKB) ( https://ckb.jax.org ), which is an interactive digital resource for interpreting complex cancer genomic profiles, providing clinical context to genomic and protein data [ , ].

Functional Assay:

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: , The Jackson Laboratory Clinical Knowledgebase (JAX) , https://ckb.jax.org.

Article Title: Basket Trials: Past, Present, and Future
Article Snippet: Online databases have been developed to determine the predictive role of molecular alterations; these include OncoKB, OncoVAR, Jackson Laboratory Clinical Knowledgebase, CIViC, Precision Medicine Knowledgebase, MyCancerGenome, Cancer Genome Interpreter, CancerVar, MetaKB, and ClinVar.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: TP53 mutational information is from the supplementary data of Yang et al.; TP53 status of each model was classified as non-pathogenic, pathogenic, or having conflicting evidence based on annotations from OncoKB, ClinVar, CIViC, and/or the Jackson Laboratory Clinical KnowledgeBase (JAX CKB). (b) Yang dataset (graphical view of TP53 mutation data is shown in Fig. a); 13 models were resistant to gemcitabine and 15 models were sensitive as determined by the evaluation of percentage tumor growth inhibition (TGI%).

Article Title: A clinical solution for tracking clonal evolution of acute myeloid leukemia after allogeneic transplantation using bulk next generation sequencing.
Article Snippet: Clinical next generation sequencing (NGS) typically relies on limited gene panels run on bulk marrow or blood.. Current computational tools for inferring clonal relationships is generally limited by the use of a small panel of pathogenic mutations to define clones.. We developed an online software (CloneTracker) that uses ‘incidentally-sequenced’ single nucleotide polymorphisms (SNPs) in the regions of recurrent somatic mutations in addition to conventional mutation data from bulk NGS gene panels to provide detailed visualizations of clonal evolution during cancer treatment, alongside clinical data.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: Briefly, information about functional effects of TP53 mutation variants was obtained from the OncoKB and compared to the information from ClinVar, CiViC, and the Jackson Laboratory Clinical KnowledgeBase (JAX CKB) databases, and from biomedical publications.

Article Title: CGE25-107: Capture Efficacy of Genomic Panels for NCCN-Recommended and Clinical Trial Associated Biomarkers.
Article Snippet: CGE25-107: Capture Efficacy of Genomic Panels for NCCNRecommended and Clinical Trial Associated Biomarkers Authors: J... VIEW MORE Volume/Issue: Volume 23: Issue 3.5 Online Publication Date: 28 Mar 2025 DOI: https://doi.org/10.6004/jnccn.2025.70 05 GET PERMISSIONS Introduction: Knowledge of treatment options, including FDA-approved targeted therapies and potential clinical trial eligibility, enables oncologists to develop optimal treatment plans for patients with advanced or metastatic cancer.. National guidelines strongly endorse testing for targeted therapies and patient participation in clinical trials.. This study analyzed commercially available NGS panels of varying sizes to assess their ability to capture genomic variants linked to NCCN-recommended and clinical trialassociated targeted treatments for high incidence cancers.

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: They host the Jackson Laboratory Clinical Knowledgebase (JAX-CKB) ( https://ckb.jax.org ), which is an interactive digital resource for interpreting complex cancer genomic profiles, providing clinical context to genomic and protein data [ , ].

Mutagenesis:

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: , The Jackson Laboratory Clinical Knowledgebase (JAX) , https://ckb.jax.org.

Article Title: Basket Trials: Past, Present, and Future
Article Snippet: Online databases have been developed to determine the predictive role of molecular alterations; these include OncoKB, OncoVAR, Jackson Laboratory Clinical Knowledgebase, CIViC, Precision Medicine Knowledgebase, MyCancerGenome, Cancer Genome Interpreter, CancerVar, MetaKB, and ClinVar.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: TP53 mutational information is from the supplementary data of Yang et al.; TP53 status of each model was classified as non-pathogenic, pathogenic, or having conflicting evidence based on annotations from OncoKB, ClinVar, CIViC, and/or the Jackson Laboratory Clinical KnowledgeBase (JAX CKB). (b) Yang dataset (graphical view of TP53 mutation data is shown in Fig. a); 13 models were resistant to gemcitabine and 15 models were sensitive as determined by the evaluation of percentage tumor growth inhibition (TGI%).

Article Title: A clinical solution for tracking clonal evolution of acute myeloid leukemia after allogeneic transplantation using bulk next generation sequencing.
Article Snippet: Clinical next generation sequencing (NGS) typically relies on limited gene panels run on bulk marrow or blood.. Current computational tools for inferring clonal relationships is generally limited by the use of a small panel of pathogenic mutations to define clones.. We developed an online software (CloneTracker) that uses ‘incidentally-sequenced’ single nucleotide polymorphisms (SNPs) in the regions of recurrent somatic mutations in addition to conventional mutation data from bulk NGS gene panels to provide detailed visualizations of clonal evolution during cancer treatment, alongside clinical data.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: Briefly, information about functional effects of TP53 mutation variants was obtained from the OncoKB and compared to the information from ClinVar, CiViC, and the Jackson Laboratory Clinical KnowledgeBase (JAX CKB) databases, and from biomedical publications.

Article Title: CGE25-107: Capture Efficacy of Genomic Panels for NCCN-Recommended and Clinical Trial Associated Biomarkers.
Article Snippet: CGE25-107: Capture Efficacy of Genomic Panels for NCCNRecommended and Clinical Trial Associated Biomarkers Authors: J... VIEW MORE Volume/Issue: Volume 23: Issue 3.5 Online Publication Date: 28 Mar 2025 DOI: https://doi.org/10.6004/jnccn.2025.70 05 GET PERMISSIONS Introduction: Knowledge of treatment options, including FDA-approved targeted therapies and potential clinical trial eligibility, enables oncologists to develop optimal treatment plans for patients with advanced or metastatic cancer.. National guidelines strongly endorse testing for targeted therapies and patient participation in clinical trials.. This study analyzed commercially available NGS panels of varying sizes to assess their ability to capture genomic variants linked to NCCN-recommended and clinical trialassociated targeted treatments for high incidence cancers.

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: They host the Jackson Laboratory Clinical Knowledgebase (JAX-CKB) ( https://ckb.jax.org ), which is an interactive digital resource for interpreting complex cancer genomic profiles, providing clinical context to genomic and protein data [ , ].

Derivative Assay:

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: , The Jackson Laboratory Clinical Knowledgebase (JAX) , https://ckb.jax.org.

Article Title: Basket Trials: Past, Present, and Future
Article Snippet: Online databases have been developed to determine the predictive role of molecular alterations; these include OncoKB, OncoVAR, Jackson Laboratory Clinical Knowledgebase, CIViC, Precision Medicine Knowledgebase, MyCancerGenome, Cancer Genome Interpreter, CancerVar, MetaKB, and ClinVar.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: TP53 mutational information is from the supplementary data of Yang et al.; TP53 status of each model was classified as non-pathogenic, pathogenic, or having conflicting evidence based on annotations from OncoKB, ClinVar, CIViC, and/or the Jackson Laboratory Clinical KnowledgeBase (JAX CKB). (b) Yang dataset (graphical view of TP53 mutation data is shown in Fig. a); 13 models were resistant to gemcitabine and 15 models were sensitive as determined by the evaluation of percentage tumor growth inhibition (TGI%).

Article Title: A clinical solution for tracking clonal evolution of acute myeloid leukemia after allogeneic transplantation using bulk next generation sequencing.
Article Snippet: Clinical next generation sequencing (NGS) typically relies on limited gene panels run on bulk marrow or blood.. Current computational tools for inferring clonal relationships is generally limited by the use of a small panel of pathogenic mutations to define clones.. We developed an online software (CloneTracker) that uses ‘incidentally-sequenced’ single nucleotide polymorphisms (SNPs) in the regions of recurrent somatic mutations in addition to conventional mutation data from bulk NGS gene panels to provide detailed visualizations of clonal evolution during cancer treatment, alongside clinical data.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: Briefly, information about functional effects of TP53 mutation variants was obtained from the OncoKB and compared to the information from ClinVar, CiViC, and the Jackson Laboratory Clinical KnowledgeBase (JAX CKB) databases, and from biomedical publications.

Article Title: CGE25-107: Capture Efficacy of Genomic Panels for NCCN-Recommended and Clinical Trial Associated Biomarkers.
Article Snippet: CGE25-107: Capture Efficacy of Genomic Panels for NCCNRecommended and Clinical Trial Associated Biomarkers Authors: J... VIEW MORE Volume/Issue: Volume 23: Issue 3.5 Online Publication Date: 28 Mar 2025 DOI: https://doi.org/10.6004/jnccn.2025.70 05 GET PERMISSIONS Introduction: Knowledge of treatment options, including FDA-approved targeted therapies and potential clinical trial eligibility, enables oncologists to develop optimal treatment plans for patients with advanced or metastatic cancer.. National guidelines strongly endorse testing for targeted therapies and patient participation in clinical trials.. This study analyzed commercially available NGS panels of varying sizes to assess their ability to capture genomic variants linked to NCCN-recommended and clinical trialassociated targeted treatments for high incidence cancers.

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: They host the Jackson Laboratory Clinical Knowledgebase (JAX-CKB) ( https://ckb.jax.org ), which is an interactive digital resource for interpreting complex cancer genomic profiles, providing clinical context to genomic and protein data [ , ].

Inhibition:

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: , The Jackson Laboratory Clinical Knowledgebase (JAX) , https://ckb.jax.org.

Article Title: Basket Trials: Past, Present, and Future
Article Snippet: Online databases have been developed to determine the predictive role of molecular alterations; these include OncoKB, OncoVAR, Jackson Laboratory Clinical Knowledgebase, CIViC, Precision Medicine Knowledgebase, MyCancerGenome, Cancer Genome Interpreter, CancerVar, MetaKB, and ClinVar.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: TP53 mutational information is from the supplementary data of Yang et al.; TP53 status of each model was classified as non-pathogenic, pathogenic, or having conflicting evidence based on annotations from OncoKB, ClinVar, CIViC, and/or the Jackson Laboratory Clinical KnowledgeBase (JAX CKB). (b) Yang dataset (graphical view of TP53 mutation data is shown in Fig. a); 13 models were resistant to gemcitabine and 15 models were sensitive as determined by the evaluation of percentage tumor growth inhibition (TGI%).

Article Title: A clinical solution for tracking clonal evolution of acute myeloid leukemia after allogeneic transplantation using bulk next generation sequencing.
Article Snippet: Clinical next generation sequencing (NGS) typically relies on limited gene panels run on bulk marrow or blood.. Current computational tools for inferring clonal relationships is generally limited by the use of a small panel of pathogenic mutations to define clones.. We developed an online software (CloneTracker) that uses ‘incidentally-sequenced’ single nucleotide polymorphisms (SNPs) in the regions of recurrent somatic mutations in addition to conventional mutation data from bulk NGS gene panels to provide detailed visualizations of clonal evolution during cancer treatment, alongside clinical data.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: Briefly, information about functional effects of TP53 mutation variants was obtained from the OncoKB and compared to the information from ClinVar, CiViC, and the Jackson Laboratory Clinical KnowledgeBase (JAX CKB) databases, and from biomedical publications.

Article Title: CGE25-107: Capture Efficacy of Genomic Panels for NCCN-Recommended and Clinical Trial Associated Biomarkers.
Article Snippet: CGE25-107: Capture Efficacy of Genomic Panels for NCCNRecommended and Clinical Trial Associated Biomarkers Authors: J... VIEW MORE Volume/Issue: Volume 23: Issue 3.5 Online Publication Date: 28 Mar 2025 DOI: https://doi.org/10.6004/jnccn.2025.70 05 GET PERMISSIONS Introduction: Knowledge of treatment options, including FDA-approved targeted therapies and potential clinical trial eligibility, enables oncologists to develop optimal treatment plans for patients with advanced or metastatic cancer.. National guidelines strongly endorse testing for targeted therapies and patient participation in clinical trials.. This study analyzed commercially available NGS panels of varying sizes to assess their ability to capture genomic variants linked to NCCN-recommended and clinical trialassociated targeted treatments for high incidence cancers.

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: They host the Jackson Laboratory Clinical Knowledgebase (JAX-CKB) ( https://ckb.jax.org ), which is an interactive digital resource for interpreting complex cancer genomic profiles, providing clinical context to genomic and protein data [ , ].

Modification:

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: , The Jackson Laboratory Clinical Knowledgebase (JAX) , https://ckb.jax.org.

Article Title: Basket Trials: Past, Present, and Future
Article Snippet: Online databases have been developed to determine the predictive role of molecular alterations; these include OncoKB, OncoVAR, Jackson Laboratory Clinical Knowledgebase, CIViC, Precision Medicine Knowledgebase, MyCancerGenome, Cancer Genome Interpreter, CancerVar, MetaKB, and ClinVar.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: TP53 mutational information is from the supplementary data of Yang et al.; TP53 status of each model was classified as non-pathogenic, pathogenic, or having conflicting evidence based on annotations from OncoKB, ClinVar, CIViC, and/or the Jackson Laboratory Clinical KnowledgeBase (JAX CKB). (b) Yang dataset (graphical view of TP53 mutation data is shown in Fig. a); 13 models were resistant to gemcitabine and 15 models were sensitive as determined by the evaluation of percentage tumor growth inhibition (TGI%).

Article Title: A clinical solution for tracking clonal evolution of acute myeloid leukemia after allogeneic transplantation using bulk next generation sequencing.
Article Snippet: Clinical next generation sequencing (NGS) typically relies on limited gene panels run on bulk marrow or blood.. Current computational tools for inferring clonal relationships is generally limited by the use of a small panel of pathogenic mutations to define clones.. We developed an online software (CloneTracker) that uses ‘incidentally-sequenced’ single nucleotide polymorphisms (SNPs) in the regions of recurrent somatic mutations in addition to conventional mutation data from bulk NGS gene panels to provide detailed visualizations of clonal evolution during cancer treatment, alongside clinical data.

Article Title: Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Article Snippet: Briefly, information about functional effects of TP53 mutation variants was obtained from the OncoKB and compared to the information from ClinVar, CiViC, and the Jackson Laboratory Clinical KnowledgeBase (JAX CKB) databases, and from biomedical publications.

Article Title: CGE25-107: Capture Efficacy of Genomic Panels for NCCN-Recommended and Clinical Trial Associated Biomarkers.
Article Snippet: CGE25-107: Capture Efficacy of Genomic Panels for NCCNRecommended and Clinical Trial Associated Biomarkers Authors: J... VIEW MORE Volume/Issue: Volume 23: Issue 3.5 Online Publication Date: 28 Mar 2025 DOI: https://doi.org/10.6004/jnccn.2025.70 05 GET PERMISSIONS Introduction: Knowledge of treatment options, including FDA-approved targeted therapies and potential clinical trial eligibility, enables oncologists to develop optimal treatment plans for patients with advanced or metastatic cancer.. National guidelines strongly endorse testing for targeted therapies and patient participation in clinical trials.. This study analyzed commercially available NGS panels of varying sizes to assess their ability to capture genomic variants linked to NCCN-recommended and clinical trialassociated targeted treatments for high incidence cancers.

Article Title: Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
Article Snippet: They host the Jackson Laboratory Clinical Knowledgebase (JAX-CKB) ( https://ckb.jax.org ), which is an interactive digital resource for interpreting complex cancer genomic profiles, providing clinical context to genomic and protein data [ , ].



Similar Products

86
Jackson Laboratory clinical knowledgebase
Clinical Knowledgebase, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/clinical+knowledgebase/clinical+jax+knowledgebase/10__1016_slash_j__cancergen__2026__04__009-55-46-50
Average 86 stars, based on 1 article reviews
clinical knowledgebase - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Jackson Laboratory jax clinical knowledgebase
Jax Clinical Knowledgebase, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/clinical+knowledgebase/clinical+jax+knowledgebase/pm41862707-224-18-21
Average 86 stars, based on 1 article reviews
jax clinical knowledgebase - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Jackson Laboratory jackson laboratory clinical knowledgebase
Jackson Laboratory Clinical Knowledgebase, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/clinical+knowledgebase/clinical+jax+knowledgebase/pm40716817-84-26-30
Average 86 stars, based on 1 article reviews
jackson laboratory clinical knowledgebase - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Jackson Laboratory jackson clinical knowledgebase (ckb)
Jackson Clinical Knowledgebase (Ckb), supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/clinical+knowledgebase/jackson+clinical+knowledgebase/pm40379905-61-8-9
Average 90 stars, based on 1 article reviews
jackson clinical knowledgebase (ckb) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Statz Bros Inc curated clinical knowledgebase
Curated Clinical Knowledgebase, supplied by Statz Bros Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/clinical+knowledgebase/curated+clinical+knowledgebase/pm40053698-522-34-9
Average 90 stars, based on 1 article reviews
curated clinical knowledgebase - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Jackson Laboratory the jackson clinical knowledgebase
The Jackson Clinical Knowledgebase, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/clinical+knowledgebase/jackson+clinical+knowledgebase/pm40154350-4-8-12
Average 90 stars, based on 1 article reviews
the jackson clinical knowledgebase - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results